R. Pasold

1.1k total citations
12 papers, 471 citations indexed

About

R. Pasold is a scholar working on Pathology and Forensic Medicine, Genetics and Neurology. According to data from OpenAlex, R. Pasold has authored 12 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 6 papers in Neurology. Recurrent topics in R. Pasold's work include Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). R. Pasold is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). R. Pasold collaborates with scholars based in Germany, United States and Austria. R. Pasold's co-authors include Rainer Krahl, Dietger Niederwieser, Gerhard Heil, J Krauter, Konstanze Döhner, Markus Schaich, Arnold Ganser, Cristina Sauerland, Brigitte Mohr and Hartmut Döhner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Antimicrobial Chemotherapy.

In The Last Decade

R. Pasold

12 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Pasold Germany 7 256 189 140 110 110 12 471
E. P. Alessandrino Italy 11 345 1.3× 110 0.6× 118 0.8× 115 1.0× 120 1.1× 26 505
RD Brunning United States 7 308 1.2× 109 0.6× 102 0.7× 91 0.8× 170 1.5× 9 497
Monica Tozzi Italy 8 139 0.5× 181 1.0× 139 1.0× 77 0.7× 91 0.8× 16 366
CE Litz United States 7 217 0.8× 107 0.6× 175 1.3× 45 0.4× 172 1.6× 9 404
Hikaru Kobayashi Japan 12 300 1.2× 124 0.7× 103 0.7× 153 1.4× 132 1.2× 24 560
Shankara Paneesha United Kingdom 11 134 0.5× 154 0.8× 154 1.1× 35 0.3× 186 1.7× 39 434
JP Greer United States 6 151 0.6× 88 0.5× 138 1.0× 87 0.8× 265 2.4× 8 452
N J Chao United States 13 327 1.3× 54 0.3× 94 0.7× 70 0.6× 168 1.5× 18 491
I. Khouri United States 9 347 1.4× 71 0.4× 86 0.6× 60 0.5× 162 1.5× 13 455
R. Champlin United States 6 162 0.6× 55 0.3× 81 0.6× 114 1.0× 114 1.0× 8 398

Countries citing papers authored by R. Pasold

Since Specialization
Citations

This map shows the geographic impact of R. Pasold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Pasold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Pasold more than expected).

Fields of papers citing papers by R. Pasold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Pasold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Pasold. The network helps show where R. Pasold may publish in the future.

Co-authorship network of co-authors of R. Pasold

This figure shows the co-authorship network connecting the top 25 collaborators of R. Pasold. A scholar is included among the top collaborators of R. Pasold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Pasold. R. Pasold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kiefer, Thomas, William Krüger, Michael Montemurro, et al.. (2008). Mobilization of hemopoietic stem cells with high‐dose methotrexate plus granulocyte–colony‐stimulating factor in patients with primary central nervous system lymphoma. Transfusion. 48(12). 2624–2628. 4 indexed citations
2.
3.
Glasmacher, Axel, Oliver A. Cornely, Andrew J. Ullmann, et al.. (2005). An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. Journal of Antimicrobial Chemotherapy. 57(2). 317–325. 69 indexed citations
4.
Korfel, Agnieszka, Peter Martus, Mohammad R. Nowrousian, et al.. (2004). Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma. British Journal of Haematology. 128(2). 177–183. 41 indexed citations
5.
Schlenk, R., Axel Benner, J Krauter, et al.. (2004). Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup. Journal of Clinical Oncology. 22(18). 3741–3750. 245 indexed citations
6.
Koenigsmann, Michael, Wolfgang Knauf, Michael Herold, et al.. (2004). Fludarabine and Bendamustine in Refractory and Relapsed Indolent Lymphoma—a Multicenter Phase I/II Trial of the East German Society of Hematology and Oncology (OSHO). Leukemia & lymphoma. 45(9). 1821–1827. 33 indexed citations
7.
Korfel, Agnieszka, Peter Martus, DK Hossfeld, et al.. (2003). A prospective Multicenter study of the BMPD regimen with or without radiotherapy for primary CNS lymphoma.. mediaTUM (Technical University of Munich). 1 indexed citations
8.
Herold, Michael, Gottfried Dölken, F. Fiedler, et al.. (2003). Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab. Annals of Hematology. 82(2). 77–79. 43 indexed citations
9.
Hasenclever, Dirk, Rainer Krahl, Wolfram Pönisch, et al.. (2002). Intermediate-dose Cytarabine Treatment Delivered at Moderate Infusion Rates for De Novo Acute Myeloid Leukemia-Results of a phase I-II Study. Leukemia & lymphoma. 43(2). 265–274. 6 indexed citations
10.
Schmitt, Barbara, Clemens‐Martin Wendtner, Michael Bergmann, et al.. (2002). Fludarabine Combination Therapy for the Treatment of Chronic Lymphocytic Leukemia. Clinical Lymphoma. 3(1). 26–35. 19 indexed citations
11.
Herold, Michael, Michael Aßmann, A. Franke, et al.. (2000). Acute Toxicity of Mitoxantrone, Chlorambucil and Prednisolone (MCP) versus MCP plus Rituximab in Low-Grade Non-Hodgkin’s Lymphoma – Interim Results of a Phase III Trial. Oncology Research and Treatment. 23(2). 164–166. 1 indexed citations
12.
Höffken, G., R. Pasold, Karl-Heinz Pflüger, et al.. (1999). An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. Journal of Antimicrobial Chemotherapy. 44(3). 367–376. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. P. Alessandrino Breakdown of academic impact, for papers by RD Brunning Breakdown of academic impact, for papers by Monica Tozzi Breakdown of academic impact, for papers by CE Litz Breakdown of academic impact, for papers by Hikaru Kobayashi Breakdown of academic impact, for papers by Shankara Paneesha Breakdown of academic impact, for papers by JP Greer Breakdown of academic impact, for papers by N J Chao Breakdown of academic impact, for papers by I. Khouri Breakdown of academic impact, for papers by R. Champlin
Rankless by CCL
2026